Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
4D Molecular Therapeutics | FDMT | Sep 19, 2024 | 13.50 | -19.74 |
51Talk Online Education Group ADR | COE | Sep 19, 2024 | 16.00 | -0.99 |
5E Advanced Materials | FEAM | Sep 19, 2024 | 0.48 | -0.46 |
60 Degrees Pharmaceuticals | SXTP | Sep 19, 2024 | 1.35 | -4.11 |
7-10 Yr Trsy Bear 3X Direxion | TYO | Sep 19, 2024 | 12.48 | +0.31 |
7-10 Yr Trsy Bull 3X Direxion | TYD | Sep 19, 2024 | 28.78 | -0.14 |
7-10 Yr Trsy Ishares | IEF | Sep 19, 2024 | 98.45 | -0.08 |
89bio | ETNB | Sep 19, 2024 | 8.29 | -0.24 |
8x8 | EGHT | Sep 19, 2024 | 1.89 | -0.53 |
908 Devices | MASS | Sep 19, 2024 | 3.84 | +4.07 |
99 Acquisition Group | NNAGU | Sep 19, 2024 | 10.60 | 0.00 |
99 Acquisition Group | NNAG | Sep 19, 2024 | 10.55 | 0.00 |
9F ADR | JFU | Sep 19, 2024 | 1.56 | +1.30 |
A SPAC I Acquisition Unit | ASCAU | Sep 19, 2024 | 2.96 | 0.00 |
A SPAC II Acquisition | ASCB | Sep 19, 2024 | 11.19 | 0.00 |
A-Mark Precious Metals | AMRK | Sep 19, 2024 | 43.43 | +0.39 |
a.k.a Brands | AKA | Sep 19, 2024 | 25.00 | +1.87 |
A.O Smith | AOS | Sep 19, 2024 | 84.29 | +1.69 |
A10 Networks | ATEN | Sep 19, 2024 | 13.98 | +1.23 |
A2Z Smart Technologies | AZ | Sep 19, 2024 | 0.69 | +3.72 |
AAA - A Rated Corporate Bond Ishares | QLTA | Sep 19, 2024 | 49.27 | +0.08 |
Aadi Bioscience | AADI | Sep 19, 2024 | 1.83 | -2.14 |
AAON | AAON | Sep 19, 2024 | 102.45 | +5.69 |
AAR | AIR | Sep 19, 2024 | 69.55 | +0.96 |
Abacus Life | ABL | Sep 19, 2024 | 9.89 | -4.90 |
Abbott Laboratories | ABT | Sep 19, 2024 | 114.15 | -0.64 |
AbbVie | ABBV | Sep 19, 2024 | 193.62 | +0.35 |
AbCellera Biologics | ABCL | Sep 19, 2024 | 2.74 | -0.36 |
Abeona Therapeutics | ABEO | Sep 19, 2024 | 5.80 | +6.42 |
Abercrombie & Fitch | ANF | Sep 19, 2024 | 139.32 | +2.86 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.